Deterioration of the protein kinase C-K-ATP channel pathway in regulation of coronary flow in hypercholesterolaemic rabbits

Citation
E. Pongo et al., Deterioration of the protein kinase C-K-ATP channel pathway in regulation of coronary flow in hypercholesterolaemic rabbits, EUR J PHARM, 418(3), 2001, pp. 217-223
Citations number
27
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
418
Issue
3
Year of publication
2001
Pages
217 - 223
Database
ISI
SICI code
0014-2999(20010427)418:3<217:DOTPKC>2.0.ZU;2-T
Abstract
We studied the effect of experimental hypercholesterolaemia/atherosclerosis on changes in coronary flow and cardiac function, induced by protein kinas e C and ATP-sensitive K+ (K-ATP) channel modulators in isolated Langendorff -perfused rabbit hearts. Both phorbol 12-myristate-13-acetate (PMA) and pho rbol 12,13-dibutyrate (PDB, 0.1 muM each), activators of protein kinase C, decreased, whereas staurosporine. (0.1)muM), a protein kinase C inhibitor, increased coronary flow and left ventricular dP/dt, an index of ventricular contractility. Glyburide (5-50 muM), a K-ATP channel inhibitor, blocked th e effect of staurosporine. The phorbol esters were without effect in the pr esence of pinacidil (5 muM), a K-ATP channel activator. Neither the protein kinase C modulators nor glyburide produced any effect on coronary flow and left ventricular contractility, when the hearts were prepared from animals either maintained on a cholesterol (1.5%)-enriched diet or treated with lo vastatin (5 mg/kg/day per os). Treatment with farnesol (1 mg/kg twice a day for 7 days intravenously) restored the reactivity of hearts from either hy percholesterolaemic or lovastatin-treated animals to protein kinase C modul ators. We conclude that non-cholesterol mevalonate products are necessary f or the functional integrity of the protein kinase C-K-ATP channel pathway i n the rabbit heart. (C) 2001 Published by Elsevier Science B.V.